Research study Program year 2023 Source: CMS Open Payments

A Phase 3 Multicenter Randomized Parallel-Design Open-Label Trial to Evaluate the Efficacy and Safety of Ly3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (Qwint-3)

ClinicalTrials.gov NCT05275400

Research payments

$5,544,909

102 payments

Through program year 2023, $5,544,909 in research payments was reported against A Phase 3 Multicenter Randomized Parallel-Design Open-Label Trial to Evaluate the Efficacy and Safety of Ly3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (Qwint-3), across 102 payments.

Paid by (largest first)
Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
ClinicalTrials.gov
NCT05275400

By program year

1 row
Year Kind Amount Payments
2023 Research $5,544,909 102

Breakdown

Who paid Research payments · program year 2023
  1. Eli Lilly and Company $5,061,816 100 payments
  2. Eli Lilly Export S.A. Puerto Rico Branch $483,093 2 payments
Who received the money Research payments · program year 2023
  1. Sky Clinical Research Network Group Organisation paid for research $452,132 4 payments
  2. Mgcendo LLC Organisation paid for research $379,936 1 payment
  3. Encore Medical Research LLC Organisation paid for research $278,764 2 payments
  4. Biopharma Informatic INC Organisation paid for research $226,253 2 payments
  5. Southern Endocrinology Associates PA Organisation paid for research $218,696 2 payments
  6. University Clinical Investigators INC Organisation paid for research $218,378 2 payments
  7. Iowa Diabetes And Endocrinology Rsrch Cntr Organisation paid for research $205,030 2 payments
  8. Nyc Research INC Organisation paid for research $202,876 2 payments
  9. Healthpartners Institute For Education Organisation paid for research $194,531 2 payments
  10. West Orange Endocrinology PA Organisation paid for research $183,638 2 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record